![]() |
市場調查報告書
商品編碼
1276353
感染監測解決方案全球市場規模,份額和行業趨勢分析:按產品/服務(軟件(本地,基於 Web,的軟件),服務),最終用戶,區域展望/預測,2023-2029Global Infection Surveillance Solutions Market Size, Share & Industry Trends Analysis Report By Product & Services (Software (On-premise and Web-based Software) and Services), By End User, By Regional Outlook and Forecast, 2023 - 2029 |
到 2029 年,感染監測解決方案市場規模預計將達到 13 億美元,預測期內復合年增長率為 12.9%。
隨著醫療保健成本的上升,對感染監測解決方案的需求預計也會增加。 此外,由於有利可圖的政府舉措,市場正在擴大。 此外,IT系統的分析處理能力得到提升,隨著IT系統的技術發展,我們支持創建用於醫療領域的分析解決方案和感染監測解決方案。
將算法與專門的數據挖掘工具、電子病歷和全自動 HAI 監控結合使用,使用基於臨床支持的信息來幫助檢測特定的臨床術語,這些都是其中的一些方法。 感染監測解決方案市場正在經歷顯著擴張,原因有多種因素,例如手術次數增加和政府為避免 HAI 制定的法規。
COVID-19 影響分析
COVID-19 大流行的爆發有利於感染監測解決方案市場。 COVID-19 大流行使全球醫療保健系統不堪重負,並增加了 COVID-19 患者感染醫療保健相關感染的機會。 衛生設施的人口減少是由於 COVID 陽性患者的急劇增加和病毒傳播率的飆升造成的。 此外,由於傳染病控制意識的增強,後疫情時期對感染監測解決方案的需求也越來越大。
市場增長因素
擴大抗生素管理計劃的採用
感染控制和流行病學 (APIC) 旨在阻止 HAI 數量的增加。 全球健康和發展關注的一個問題是抗菌素耐藥性 (AMR)。 據世界衛生組織稱,抗菌素耐藥性是全球十大對人類健康的危害之一。 2015 年,世衛組織推出了全球抗微生物藥物耐藥性和使用監測系統(GLASS),該系統整合了人類 AMR 和藥物使用監測信息。 為了滿足醫療機構的需求,一些市場進入者正在推出抗生素管理監測解決方案。 基於此,感染監測解決方案市場預計將支持市場增長。
新興國家的巨大增長機會
預計印度、中國、巴西、俄羅斯、拉丁美洲和東南亞等發展中經濟體的感染監測解決方案市場潛力巨大。 這是因為一半以上的人口集中在印度和中國,而世界上很大一部分人口都集中在這些地區。 在這些國家,由於人均收入的增加、醫療意識的提高、醫院和診所數量的增加以及患者數量的增加,對更好的醫療保健服務的需求也在增加。 這些國家的醫療器械製造受到融合感染控制技術的新市場的出現的推動,市場擴張的前景看好。
市場製約因素
小型組織的引進成本太高
高互操作性和部署成本使得面向醫療保健提供商的 IT 軟件解決方案部署起來既困難又昂貴。 在醫療領域,互聯網接入整合在小型醫療企業中較為常見,因為不同網絡難以搭建,無線化的可能性很小,並且需要嚴格的安全措施來防止數據洩露,這變得困難。 此外,感染監控軟件非常昂貴。 此外,為售後設備集成構建定制接口需要額外的驗證和確認,增加了醫療保健組織的總擁有成本。 較小的醫院和醫療集團無力承擔這些額外費用,因此無法實施該解決方案。 因此,感染監測解決方案市場的增長預計將放緩。
產品和服務的前景
感染監測解決方案市場按產品和服務細分為軟件和服務。 到 2022 年,服務部門將在感染監測解決方案市場中佔據重要的收入份額。 這是因為感染監控軟件需要持續的產品更新和技術支持。 客戶(醫療機構)需要訪問供應商公司的技術知識庫、產品支持團隊的幫助以及應用程序管理技能,從而推動產品支持和維護服務的擴展。
軟件展望
按軟件劃分,感染監控解決方案市場分為本地軟件和基於網絡的軟件。 到 2022 年,感染監測解決方案市場在內部部署部分的收入份額最大。 這背後是對安全訪問醫療 IT 系統的需求,以及降低數據洩露和外部攻擊風險的需求。 因此,許多醫療保健公司青睞本地軟件解決方案來確保患者數據的安全。 重用現有存儲和服務器的能力是一個額外的好處,特別是對於從一個系統升級或遷移到另一個系統的公司而言。
最終用戶視角
按最終用戶劃分,感染監測解決方案市場分為醫院、長期護理機構等。 到 2022 年,感染監測解決方案市場將由醫院部門主導。 考慮到 HAI 發生頻率的增加以及相關利益相關者的經濟負擔,醫院正在引入感染控制產品和服務。 此外,由於患者人數眾多和手術部位感染 (SSI) 發生率上升,市場正在擴大。
區域展望
按地區劃分,分析了北美、歐洲、亞太地區和 LAMEA 的感染監測解決方案市場。 到 2022 年,北美地區將以最高的收入份額引領感染監測解決方案市場。 由於醫療保健 IT 解決方案的激增以遏制不斷上升的醫療成本、醫療機構的快速整合以及美國 HAIs 患病率上升等因素,北美市場正在發生重大變化。 北美大量感染監測解決方案的另一個重要方面是該地區的商業財富。
合作和收購是市場進入者採取的主要策略。 根據基數矩陣的分析,甲骨文公司在感染監控解決方案市場處於領先地位。 Becton、Dickinson and Company、Wolters Kluwer N.V. 和 Baxter International, Inc. 等公司是感染監測解決方案市場的領先創新者。
這份市場研究報告涵蓋了對市場主要利益相關者的分析。 本報告介紹的主要公司有 Becton, Dickinson and Company、Oracle Corporation (Cerner Corporation)、Wolters Kluwer N.V.、BioMerieux S.A.、Baxter International, Inc. Harris Healthcare (Constellation Software, Inc.)、Securitas AB、OSI Systems, Inc. (Spacelabs Healthcare)、Gojo Industries, Inc. 和 Merative L.P.(Francisco Partners)。
The Global Infection Surveillance Solutions Market size is expected to reach $1.3 billion by 2029, rising at a market growth of 12.9% CAGR during the forecast period.
The goal of infection surveillance solutions is to accurately apply preventive actions by continuously monitoring and interpreting data related to health. Data from infection surveillance is used to assess and guard against the harm preventable infections can do to patients and healthcare professionals. Hand hygiene, injection safety, antimicrobial resistance, surgical site infections, and hospitals that are open both during and after emergencies are all impacted by infection prevention and control.
During the projected period, key factors driving market growth include increasing antibiotic resistance among bacteria and increasing usage of automation in healthcare settings. In addition, increased hospital stays result from increased surgical procedures performed globally. There will consequently be an increase in the number of patients who contract HAIs.
The demand for solutions for infection surveillance is also anticipated to increase as healthcare costs rise. The market has also been expanding as a result of advantageous government initiatives. Additionally, the ability of IT systems to process analytics has increased, and this, together with technological developments in IT systems, is assisting in the creation of analytical or infection surveillance solutions for use in the healthcare sector.
The use of algorithms with specialized data mining tools, electronic medical records, and completely automated HAI surveillance using clinical support-based information that aids in the detection of specific clinical words are some of these methods. The market for infection surveillance solutions is experiencing significant expansion due to several causes, including increased surgeries and government rules to avoid HAIs.
COVID-19 Impact Analysis
The COVID-19 pandemic outbreak was beneficial for the market for infection control surveillance solutions. The COVID-19 pandemic has put a strain on the global healthcare system and raised the chance of COVID-19 patients contracting a healthcare-associated infection. The overpopulation of healthcare facilities was caused by the exponential growth in COVID-positive patients and the fast-increasing rate of viral transmission. In addition, the increased awareness of infection control resulted in increased demand for infection surveillance solutions even during the post-pandemic period.
Market Growth Factor
Growing adoption of antimicrobial stewardship programs
Infection Control and Epidemiology (APIC) aims to stop the rising number of HAIs. A concern to world health and development is antimicrobial resistance (AMR). According to the WHO, one of the top 10 worldwide public health hazards to humanity is AMR. WHO introduced the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015, integrating information from human AMR and drug use surveillance. To meet the demands of healthcare facilities, several market participants have come up with surveillance solutions for antimicrobial stewardship. In light of this, the infection surveillance solutions market is predicted to support the market growth.
Significant growth opportunities in emerging markets
In nations with rising economies like India, China, Brazil, Russia, and those in Latin America and Southeast Asia, there are likely to be significant potential prospects for the infection surveillance solutions market. This is because a significant amount of the world's population, with more than half living in India and China, is concentrated in these areas. The need for better healthcare services has grown in these nations due to rising per capita income, rising healthcare awareness, an increase in hospitals & clinics, and a large patient population. The manufacturing of medical devices in these nations is being pushed by the rise of new markets to embrace infection control technology, creating prospects for market expansion.
Market Restraining Factor
Cost of deployment is unaffordable for small organizations
The high cost of interoperability and deployment makes it difficult and expensive to implement IT software solutions for healthcare organizations. Smaller healthcare businesses have more difficulty integrating internet access since it is difficult to set up different networks in healthcare contexts, there are few wireless possibilities, and rigorous security measures are required to prevent data breaches. In addition to this, infection surveillance software can be quite pricey. In addition, the construction of a bespoke interface for the integration of a device after sales involves additional validation and verification, which adds to the overall cost of ownership for healthcare providers. Smaller hospitals & healthcare groups are unable to pay these additional costs and hence do deploy the solutions. Due to this, the infection surveillance solutions market is predicted to witness slow growth.
Product & Services Outlook
By product & services, the infection surveillance solutions market is segmented into software and services. The services segment covered a substantial revenue share in the infection surveillance solutions market in 2022. This is because infection surveillance software needs ongoing product updates and technical assistance. Clients' (healthcare providers') need for access to the vendor company's technical knowledge base, assistance from its product support team, and the acquisition of application management skills are fuelling the expansion of the product support & maintenance services.
Software Outlook
Under software, the infection surveillance solutions market is divided into on-premise software and web-based software. In 2022, the on-premise segment witnessed the largest revenue share in the infection surveillance solutions market. This is due to the necessity for safe access to healthcare IT systems as well as the need to reduce the danger of data breaches and outside attacks. As a result, many healthcare businesses favor on-premise software solutions to guarantee the security of their patient data. Reusing existing storage and server gear is an additional advantage, especially for businesses upgrading or migrating from one system to another.
End User Outlook
By end-user, the infection surveillance solutions market is categorized into hospitals, long-term care facilities and others. In 2022, the hospital segment registered the maximum revenue share in the infection surveillance solutions market. Hospitals have adopted infection control goods and services due to the increasing frequency of HAIs and the associated financial burden on stakeholders. The market is also expanding due to the high patient volume and rising incidence of surgical site infections (SSIs).
Regional Outlook
Region wise, the infection surveillance solutions market is analyzed across North America, Europe, Asia Pacific and LAMEA. In 2022, the North America region led the infection surveillance solutions market by generating the highest revenue share. Due to factors like the widespread use of healthcare IT solutions to contain the rise in healthcare costs, rapid consolidation of healthcare providers, and the rising prevalence of HAIs in the US, the market in North America is seeing major changes. Another important aspect of North America's significant market share in infection surveillance solutions is the abundance of businesses in the region.
The major strategies followed by the market participants are Partnerships and Acquisition. Based on the Analysis presented in the Cardinal matrix; Oracle Corporation is the forerunner in the Infection Surveillance Solutions Market. Companies such as Becton, Dickinson and Company, Wolters Kluwer N.V., and Baxter International, Inc. are some of the key innovators in the Infection Surveillance Solutions Market.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Oracle Corporation (Cerner Corporation), Wolters Kluwer N.V., BioMerieux S.A., Baxter International, Inc., Harris Healthcare (Constellation Software, Inc.), Securitas AB, OSI Systems, Inc. (Spacelabs Healthcare), Gojo Industries, Inc. and Merative L.P. (Francisco Partners)
Recent Strategies Deployed in Infection Surveillance Solutions Market
Partnerships, Collaborations and Agreements:
Nov-2022: Wolters partnered with Microsoft, a technology corporation, to enable healthcare organizations to offer better care and service to their customers. Through this acquisition, integrating Microsoft Azure cloud platform with Kluwer's powerful software services for healthcare would allow Wolters' to support virtual care providers and payers to generate and deploy offerings helpful in keeping engaged their patients and members.
Nov-2022: Oracle Cerner came into partnership with Labcorp, a life-science enterprise, for the management of hospital-based laboratories. Through this partnership, Labcorp's diagnostic information capabilities would empower Cerner to advance Cerner's offering facilitating to eliminate manual processes in the labs easing out the information sharing all over the health system, enabling to make quick diagnostic decisions and enhancing patient care.
Sep-2022: BioMerieux announced a partnership with BrightInsight, Inc., a medtech-regulated digital health solutions provider, to offer a Clinical Digital Solution for diagnostics allowing improved clinical decision backing for disease domains all over the diagnostic tests. Utilizing the capabilities of compliant BrightInsight Platform and BrightInsight Disease Management offering, delivering high-level regulated digital health software as a Medical Device categorization, BioMerieux would be able to offer healthcare sector enhanced clinical workflows and contextualize disease awareness and empower clinicians to make actionable informed decisions. Moreover, the partnership would enable BioMerieux to make developments in Clinical Digital solutions for diagnostics.
Jun-2022: BD partnered with Mayo Clinic Platform, a patientcare technological solutions provider, for providing access to patient data from Mayo Clinic Platform. With this partnership, utilizing the power of Mayo Clinic's in delivering advance dataset, and historical data for predictive modeling would enable BD to deliver services that increase clinical trials efficiency and access to patient data utilizing Mayo Clinic Platform. Moreover, Mayo Clinic's data would support BD to advance its product and smoothen medical device regulatory submissions.
Aug-2021: Baxter signed a partnership with Amazon Web Services (AWS), an IT service management enterprise, to enhance enterprise digital transformation. Through this partnership, leveraging the power of the cloud services suite offered by AWS would allow Baxter to propel the growth of Baxter's technology infrastructure enhancing the potential of healthcare data and leading to better patient care.
Product Launches and Product Expansions:
Apr-2023: BioMerieux announced the launch of BIOFIRE FIREWORKS, a powerful software with a user-friendly interface, personalized filters, and smooth integration, for BIOFIRE Systems for making laboratory services and data-based decisions enhanced and quick. BIOFIRE FIREWORKS would be an introduction to the BIOMERIEUX VISION SUITE-a portfolio of Data and IT Solutions for delivering enhanced efficiency and productivity to laboratories across the world. Integrating the potential of all BIOFIRE FILMARRAY systems into one centralized place, the software would provide real-time connectivity to both central and off-site labs. BIOFIRE FILMARRAY systems offer data access from anywhere and at any time improving laboratories workflow to easily manage all its operations delivering better patient care.
Sep-2022: Becton Dickinson announced the launch of BD Research Cloud, a cloud-centered software tool to smoothen flow cytometry workflow helpful in empowering scientists the ability of experimentation with faster time to insights all over immunology, virology, oncology, and infectious disease monitoring. BD Research Cloud would enable users to combine all flow cytometry workflow steps beneficial in creating reagent panels, integrate instruments with data analysis software, store experimental data. The new offering would be a robust and all-inclusive platform connecting instruments, reagents, and data analysis, supporting scientists to potentially discover research for drug development.
May-2022: BD launched automated, infectious disease molecular diagnostics platform. The powerful BD COR™ MX instrument would be a latest analytic instrument option supporting BD COR System. The offering would integrate and automate the entire molecular laboratory workflow starting from sample processing to diagnostic test result for sizeable labs, mitigating the requirement for sorting specimens.
Acquisitions and Mergers:
Jul-2022: BD acquired Parata Systems, a pharmacy automation solutions provider, for offering patient safety solutions. With this acquisition, Parata's expertise in delivering pharmacy automation services would be combined with BD's transformative solutions capabilities to develop suite of advanced pharmacy automation offerings strengthening a growing network of pharmacies to lower costs, improve patient safety and patient experience to serve retail, hospital, and pharmacies.
Apr-2022: BioMerieux S.A. completed the acquisition of Specific Diagnostics, a fast AST solution focused organization, to combat the antimicrobial resistance-a threat with infections from antibiotic resistant pathogens. With this acquisition, integration of Specific Diagnostics' REVEAL Rapid AST system into BioMerieux's suite of microbiology would provide strength to clinicians and laboratories offering enhanced patient outcomes supporting broad distribution network.
Dec-2021: BD took over Scanwell Health, at-home medical testing services provider, for broadening and scaling up the digital at-home medical testing. With this acquisition, leveraging the power of Scanwell Health in offering at-home medical testing facilities would boost BD's capability to deliver its customers at-home diagnostic tests for an extensive range of infectious diseases, including group A strep, Covid-19/influenza A+B, alongside scaling the digital at-home medical testing.
Dec-2021: Baxter International acquired Hillrom, a medical technology provider, to better serve patients, and clinicians. Through this acquisition, combining the Baxter's connectivity technology with Hillrom's Medical Diagnostic Equipment offerings would support Baxter to deliver advanced digital healthcare and better patient care services beneficial in reducing cost and enhancing workflow efficiency.
Market Segments covered in the Report:
By Product & Services
By End User
By Geography
Companies Profiled
Unique Offerings from KBV Research
List of Figures